Academic - Publications
Other PublicationsO1 Northern Regional Health Authority Advisory Committee on Disability. Services for people with a physical disability in the Northern Region. Northern Regional Health Authority 1989. Chairman of Committee and author of report.
O2 Barnes MP. The efficacy of Tizanidine in the treatment of spasticity in patients with multiple sclerosis. Sandoz Pharmaceuticals 1991
O3 Barnes MP. What is head injury? - Headway, National Head Injuries Association Booklet 1993
O4 British Society of Rehabilitation Medicine/Association of British Neurologists/Neuro Concern of Medical Charities. Neurological Rehabilitation in the United Kingdom - Report of a Working Party 1993. Member of Working Party.
O5 Williams AC, Barnes MP, Brookes GB, et al (Eds). The Management of Focal Dystonia. Porton Products 1993
O6 Barnes
MP. Community based rehabilitation - international perspectives
and current priorities.
ActionAid Disability
News 1993; 4: 3-5
O7 Barnes
MP. A new-style therapist for the real world.
Therapy
Weekly 1994; 20: 47
O8 Barnes
MP. Rehabilitation medicine - new wine in an old bottle.
The
Darlington Postgraduate 1994; 13: 49-51
O9 Jones
C, Barnes MP. Multiple sclerosis: a new approach.
Primary
Health Care 1996; 6(8)
O10 Barnes
MP. Newcastle Community MS Team. Way Ahead. News
From the MS Nurse Forum,
Issue No 1, 1997
O11 Barnes
MP. Treating and nursing patients with multiple sclerosis.
Nursing
Standard 1997; 11(23): 42-44
O12 Barnes
MP, Stephenson J. Rehabilitation in multiple sclerosis.
Multiple
Sclerosis Clinical & Laboratory Research 1998; 4:
S16
O13 Barnes
MP. Foreword for Spasticity Rehabilitation. Sheean G (Ed).
Churchill
Communications Europe Ltd, London 1998
O14 British Society of Rehabilitation Medicine. Rehabilitation after traumatic brain injury. A working party report of the British Society of Rehabilitation Medicine. BSRM, London 1998. Member of Working Party.
O15 Barnes
MP. Foreword for Parkinson's and Driving. McMillan J,
Turner G (Eds).
Parkinson's Disease Society, London 1998
O16 Barnes
MP. Modern management of spasticity: using a combined approach.
Progress
in Neurology & Psychiatry 1999; 3(3): 26-30
O17 Barnes MP (Chair of Working Party). Basics of best practice in the management of multiple sclerosis. A report by the MS Society and the Multiple Sclerosis Research Trust. London, 1999
O18 Barnes MP. What is head injury? 2nd Ed. Headway, National Head Injuries Association Booklet 2000
O19 Barnes MP. Management and treatment of multiple sclerosis within primary care. Primary Care in the New NHS (APCGT) Autumn 2000; 125-126 & 132
O20 Barnes MP, Benecke R, Brashear A, et al. Neuromuscular blockade with botulinum toxin: past present and future. Review and Recommendations from an Expert Panel Meeting. Elan Pharmaceuticals 2001
O21 Ward A, Barnes MP, Bhakta B, et al. The management of adults with spasticity using botulinum toxin: a guide to clinical practice. Ipsen Ltd, April 2001
O22 CD-ROM: Arm rehabilitation measurement. Measuring arm function in neurological rehabilitation: qualitative and quantitative approaches. EU Tide Project DE4203
O23 Barnes MP. Abstract Review: Current Research & Expert Commentary. Management of spasticity. Medical Education Network, April 2002 (Guest Editor)
O24 British Society of Rehabilitation Medicine, Association of Personal Injury Lawyers and Royal College of Physicians - Joint Speciality Committee in Rehabilitation. Guide to best practice at the interface between rehabilitation and the medico-legal process. (Co-Chairs: Grahame Codd and Michael Barnes). BSRM, London 2006
025 Barnes MP. Botulinum toxin. Open Door MS Trust Newsletter. February 2008
026 Barnes M. How to adjust the dose, the volume and the number of injections to optimize the effect of botulinum toxin A at target muscles? From theory to practice. Ipsen Newsletter 2008
027 Prospective, randomized, observer-blind, parallel-group, multi-center trial to assess efficacy and safety of two different dilutions of NT 201 (Xeomin) in patients with upper limb spasticity. (Co-ordinating investigator for study by Merz Pharmaceuticals)
